Where thousands of former Health and Human Services employees will work next is unknown, but biopharma companies likely ...

Companies are announcing significant investments in U.S. manufacturing in response to looming tariffs. An AstraZeneca ...

The expansion is a good signal for an industry that slowed down, both in Chicago and nationwide, as interest rates rose and ...

Adjusted diluted EPS for the quarter was $0.89, reflecting challenges in volume and product mix. Silberhorn announced Project Fortify Phase 2, aimed at achieving $13 million to $15 million in ...

Q1 2025. Management View. CEO Marc Bitzer highlighted a solid Q1 performance with 2% organic sales growth and EBIT margins of a ...